Drug EfficacyLarsucosterol was safe and well tolerated, with fewer treatment-emergent adverse events compared with standard of care, and reductions in mortality at 90 days were significant in the U.S. patients for both dosage arms of larsucosterol.
Product UtilityThe ALZET osmotic pump portfolio is a valuable tool in animal research, offering continuous delivery of drugs and hormones at controlled rates.
Strategic PartnershipsCollaboration with Charles River could drive ALZET's growth while DURECT focuses on larsucosterol.